Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years
…, J Buchanan, MK Doyle, EC Hsia, T Gathany… - Annals of the …, 2011 - ard.bmj.com
Objective To evaluate changes in baseline patient characteristics and entry criteria of
randomised, controlled studies of tumour necrosis factor alpha (TNFα) inhibitors in rheumatoid …
randomised, controlled studies of tumour necrosis factor alpha (TNFα) inhibitors in rheumatoid …
Safety and efficacy of subcutaneous golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: final 5-year results of the GO-FORWARD trial
…, S Hall, SC Bae, C Han, TA Gathany… - The Journal of …, 2016 - jrheum.org
Objective. To evaluate the safety and efficacy of golimumab (GOL), a human antitumor
necrosis factor antibody, in patients with active rheumatoid arthritis (RA) despite methotrexate (…
necrosis factor antibody, in patients with active rheumatoid arthritis (RA) despite methotrexate (…
The effect of golimumab therapy on disease activity and health-related quality of life in patients with ankylosing spondylitis: 2-year results of the GO-RAISE trial
…, J Braun, M Mack, B Hsu, TA Gathany… - The Journal of …, 2014 - jrheum.org
Objective. To evaluate the effects of golimumab therapy on achieving inactive disease or
major improvement, as assessed by the Ankylosing Spondylitis Disease Activity Score (ASDAS)…
major improvement, as assessed by the Ankylosing Spondylitis Disease Activity Score (ASDAS)…
[PDF][PDF] Efficacy and safety of subcutaneous golimumab in methotrexate‐naive patients with rheumatoid arthritis: Five‐year results of a randomized clinical trial
…, B Pons‐Estel, C Han, TA Gathany… - Arthritis Care & …, 2016 - Wiley Online Library
Objective To evaluate the safety and efficacy of golimumab through 5 years in adults with
active rheumatoid arthritis (RA) who had not previously received methotrexate (MTX). Methods …
active rheumatoid arthritis (RA) who had not previously received methotrexate (MTX). Methods …
Effect of golimumab on patient-reported outcomes in rheumatoid arthritis: results from the GO-FORWARD study
…, EC Hsia, J Buchanan, T Gathany… - The Journal of …, 2012 - jrheum.org
Objective. To evaluate the effect of golimumab on physical function, general health, and
fatigue in patients with active rheumatoid arthritis (RA) despite methotrexate (MTX) therapy. …
fatigue in patients with active rheumatoid arthritis (RA) despite methotrexate (MTX) therapy. …
Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early …
…, C Pendley, D Baker, M Bala, T Gathany… - The Journal of …, 2007 - jrheum.org
OBJECTIVE: To determine if changes in biomarkers of inflammation and bone turnover in
response to treatment with infliximab plus methotrexate (MTX) versus MTX alone are …
response to treatment with infliximab plus methotrexate (MTX) versus MTX alone are …
The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial
CO Bingham, M Weinblatt, C Han, TA Gathany… - The Journal of …, 2014 - jrheum.org
Objective. To evaluate the effects of intravenous (IV) golimumab 2 mg/kg + methotrexate (MTX)
on patient-reported measures of health-related quality of life (HRQOL) in patients with …
on patient-reported measures of health-related quality of life (HRQOL) in patients with …
Involving students in problem solving
TA Gathany - The Mathematics Teacher, 1979 - pubs.nctm.org
Having students consider variations of a familiar problem can help to involve them in
problem solving and often leads to interesting new problems.
problem solving and often leads to interesting new problems.
Comparative Efficacy of Adalimumab, Golimumab, and Infliximab in the Treatment of Patients with Ulcerative Colitis: An Induction Analysis: 1707
…, J Rizzo, MK Queener, T Gathany… - Official journal of the …, 2013 - journals.lww.com
Purpose: Adalimumab (ADA), golimumab (GLM), and infliximab (IFX) are anti-tumor necrosis
factor (anti-TNF) therapies approved for treating ulcerative colitis (UC). Clinical trials of …
factor (anti-TNF) therapies approved for treating ulcerative colitis (UC). Clinical trials of …
Early and Sustained Remission after Treatment with Subcutaneously Administered Golimumab Is Associated with Normalized Health-Related Quality of Life in …
…, C Marano, R Strauss, C Han, T Gathany… - Official journal of the …, 2013 - journals.lww.com
Purpose: The PURSUIT studies were randomized, double-blind, placebo-controlled studies
to evaluate the safety and efficacy of subcutaneous (SC) golimumab (GLM) in adults with …
to evaluate the safety and efficacy of subcutaneous (SC) golimumab (GLM) in adults with …